SCHEMBL4930759

SCHEMBL4930759

Cc1cc2nc(CCC(N)C(=O)NO)n(C3CCCCC3)c2cc1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 9/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ KCNH2 Q12809 1/20 0.36
▸ CCNT1 O60563 2/20 0.36
▸ CDK9 P50750 2/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ MAPT P10636 1/20 0.36
▸ GFER P55789 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ HDAC6 Q9UBN7 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ HDAC8 Q9BY41 1/20 0.36
▸ RGS12 O14924 1/20 0.35
▸ USP2 O75604 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ BLM P54132 1/20 0.35
▸ KEAP1 Q14145 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4930747 1.00 HDAC1 (0.40) HDAC1L3MBTL1KCNH2CCNT1CDK9
SCHEMBL4928960 0.84 HDAC1 (0.48) HDAC1HDAC6HDAC8
SCHEMBL4928967 0.84 HDAC1 (0.48) HDAC1HDAC6HDAC8
SCHEMBL4929059 0.84 KCNH2 (0.44) HDAC1KCNH2HDAC6POLB
SCHEMBL4929072 0.84 KCNH2 (0.44) HDAC1KCNH2HDAC6POLB
SCHEMBL4935437 0.77 NTRK1 (0.41) KCNH2KDM4EALDH1A1MAPTHDAC6
SCHEMBL4935414 0.77 NTRK1 (0.41) KCNH2KDM4EALDH1A1MAPTHDAC6
SCHEMBL4933134 0.77 NTRK1 (0.44) HDAC1HDAC6HSD17B10HDAC8POLB
SCHEMBL4932046 0.77 NTRK1 (0.44) HDAC1HDAC6HSD17B10HDAC8POLB
SCHEMBL4936237 0.77 NTRK1 (0.41) KCNH2KDM4EALDH1A1MAPTHDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080132539-A1 Hydroxamic Acid Derivative And Age Generation Inhibitor Containing The Derivative KUREHA CORPORATION (JP) 2008-06-05 — — US disclosed
EP-1707560-A1 HYDROXAMIC ACID DERIVATIVE AND AGE GENERATION INHIBITOR CONTAINING THE DERIVATIVE Kureha Corporation (JP) 2006-10-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080132539-A1 Hydroxamic Acid Derivative And Age Generation Inhibitor Containing The Derivative HDAC5, HDAC1, HDAC9 HDAC1 2/4885L3MBTL1 4626/4885KCNH2 4725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback